Key result
T3 upregulates hepatic LRP1 protein expression and enhances apoE uptake post-transcriptionally.
Why the study?
The atherogenic effects of hypothyroidism on lipid metabolism could partly result from reduced clearance of remnant lipoproteins, prompting investigation into hepatic LRP1 expression and its regulation by T3 treatment.
Does 3,3',5-triiodo-L-thyronine (T3) treatment restore hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression and function in experimental models of hypothyroidism?
Does 3,3',5-triiodo-L-thyronine (T3) treatment restore hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression and function in experimental models of hypothyroidism?
This preclinical study identifies post-transcriptional downregulation of hepatic LRP1 as a novel mechanism contributing to reduced remnant lipoprotein clearance and atherogenic dyslipidemia in hypothyroidism.
Answers are grounded in this paper and cite their sources.
T3 may enhance remnant clearance via post-transcriptional LRP1 upregulation in models; hypothesis-generating for hypothyroid dyslipidemia mechanisms.
BACKGROUND: The atherogenic effects of hypothyroidism on lipid metabolism could result, in part, from the reduced clearance of remnant lipoproteins. In this study, we investigated the expression of hepatic low-density lipoprotein receptor-related protein 1 (LRP1), a receptor for remnant lipoproteins, in hypothyroidism and the effect of 3,3',5-triiodo-L-thyronine (T3) treatment on hepatic LRP1 expression. METHODS: C57BL/6 mice were fed a normal diet (control group) or a low-iodine diet supplemented with 0.15% propylthiouracil (PTU/LI group) for 4 weeks. Mice in the PTU/LI group were injected intraperitoneally with T3 (0, 30, and 150 μg/kg of body weight) for 7 days. HepG2 cells were incubated in fetal bovine serum or charcoal-stripped fetal bovine serum with various concentrations of T3. The expression and function of LRP1 in liver samples and cells were analyzed. RESULTS: Hypothyroidism was successfully induced in PTU/LI mice. Hepatic LRP1 protein expression was lower in the PTU/LI group than in the control group. T3 treatment upregulated hepatic LRP1 protein expression in PTU/LI mice. LRP1 expression in HepG2 cells was reduced after incubation in the medium containing charcoal-stripped fetal bovine serum, which mimics hypothyroidism in vitro, and was recovered by T3 treatment. The protein expression of LRP1 in HepG2 cells was increased by T3 treatment in a dose-dependent manner up to 2.0 nM T3. However, LRP1 mRNA transcription was not affected by hypothyroidism conditions or T3 treatment, either in liver samples or in HepG2 cells. T3 treatment on HepG2 cells increased cellular uptake of lipid-conjugated apolipoprotein E through LRP1. CONCLUSIONS: Our data demonstrate that hepatic LRP1 expression and function decrease in hypothyroidism and are regulated by the thyroid hormone. These results suggest that in hypothyroidism, decreased expression of hepatic LRP1 may be associated with reduced clearance of circulating remnant lipoproteins.
No takes yet. Share an insight, caveat, or question.
Moon et al. (2013) studied Hypothyroidism and atherogenic dyslipidemia. 3,3',5-triiodo-L-thyronine (T3) vs. Normal diet control mice; vehicle (0 μg/kg T3) in PTU/LI mice; untreated charcoal-stripped FBS in HepG2 cells was evaluated on Hepatic low-density lipoprotein receptor-related protein 1 (LRP1) protein and mRNA expression, and cellular uptake of lipid-conjugated apolipoprotein E. T3 treatment upregulated hepatic LRP1 protein expression in hypothyroid mice and dose-dependently increased LRP1 protein and apoE uptake in HepG2 cells without altering LRP1 mRNA.
Synapse has enriched 10 related papers. Consider them for comparative context: